Zobrazit minimální záznam

dc.contributor.authorJampílek, Josef
dc.contributor.authorPlachá, Daniela
dc.date.accessioned2022-04-11T08:33:09Z
dc.date.available2022-04-11T08:33:09Z
dc.date.issued2021
dc.identifier.citationPharmaceutics. 2021, vol. 13, issue 12, art. no. 1994.cs
dc.identifier.issn1999-4923
dc.identifier.urihttp://hdl.handle.net/10084/146019
dc.description.abstractSince the worldwide incidence of bone disorders and cartilage damage has been increasing and traditional therapy has reached its limits, nanomaterials can provide a new strategy in the regeneration of bones and cartilage. The nanoscale modifies the properties of materials, and many of the recently prepared nanocomposites can be used in tissue engineering as scaffolds for the development of biomimetic materials involved in the repair and healing of damaged tissues and organs. In addition, some nanomaterials represent a noteworthy alternative for treatment and alleviating inflammation or infections caused by microbial pathogens. On the other hand, some nanomaterials induce inflammation processes, especially by the generation of reactive oxygen species. Therefore, it is necessary to know and understand their effects in living systems and use surface modifications to prevent these negative effects. This contribution is focused on nanostructured scaffolds, providing a closer structural support approximation to native tissue architecture for cells and regulating cell proliferation, differentiation, and migration, which results in cartilage and bone healing and regeneration.cs
dc.language.isoencs
dc.publisherMDPIcs
dc.relation.ispartofseriesPharmaceuticscs
dc.relation.urihttps://doi.org/10.3390/pharmaceutics13121994cs
dc.rights© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.cs
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/cs
dc.subjectnanomaterialscs
dc.subjectnanocompositescs
dc.subjectcartilagecs
dc.subjectbonescs
dc.subjectimplantscs
dc.subjecthealingcs
dc.subjectmusculoskeletal disorderscs
dc.titleAdvances in use of nanomaterials for musculoskeletal regenerationcs
dc.typearticlecs
dc.identifier.doi10.3390/pharmaceutics13121994
dc.rights.accessopenAccesscs
dc.type.versionpublishedVersioncs
dc.type.statusPeer-reviewedcs
dc.description.sourceWeb of Sciencecs
dc.description.volume13cs
dc.description.issue12cs
dc.description.firstpageart. no. 1994cs
dc.identifier.wos000736750600001


Soubory tohoto záznamu

Tento záznam se objevuje v následujících kolekcích

Zobrazit minimální záznam

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.